Nanoveu : Broker Briefing Investor Webinar Presentation

For personal use only

Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 [phone] www.nanoveu.com

ASX RELEASE	24 March 2022
	ASX: NVU

Broker Briefing Investor Webinar Presentation

Nanoveu Limited ("Nanoveu") participated in a Broker Briefing Investor Webinar on Thursday 24 March 2022 at 12.10pm AEDT / 9.10am WST.

A copy of the investor presentation delivered during the webinar is attached. - Ends -

This announcement has been authorised for release by Nanoveu's Managing Director and CEO

For further information, please	For media / investor enquiries,
contact:	please contact:
Alfred Chong	Jane Morgan
Managing Director and CEO	Investor Relations
t: [phone]	t: 0405 555 618
e: [e-mail]	e: [e-mail]

About Nanoveu Limited

We are technology innovators who specialize in modern, cutting-edge nanotechnology that improve the way we live, from reducing contagious transmissions on high touch points to immersive vision-based entertainment. https://www.nanoveu.com/

Nanoshield - is a film which uses a patented polymer of Cuprous embedded film to self-disinfect surfaces. Nanoshield antiviral protection which is available in a variety of shapes and forms, from mobile screen covers, to mobile phone cases and as a PVC commercial film, capable of being applied to a number of surfaces such as doorhandles and push panels. The perfectly clear plastic film contains a layer of charged copper nanoparticles which have antiviral and antimicrobial properties. This technology is also being applied to fabric applications targeting use in the personal protective equipment sector.

EyeFly3D - is a film applied to digital displays that allowed users to experience 3D without the need for glasses on everyday mobile handheld devices.

Customskins - are vending machines capable of precisely applying screen covers to mobile phones with an alignment accuracy of 150 microns.

EyeFyx - currently in research and development stage, EyeFyx is a vision correction solution using hardware and software to manipulate screen output addressing long-sightedness without the need to wear reading glasses.

ersonal use only

(ASX:NVU)

Cutting-edge antiviral nanotechnology reducing contagious transmissions on high touch points

INVESTOR PRESENTATION

MARCH 2022

ersonal use only

DISCLOSURE AND DISCLAIMER

The information in this presentation has been prepared by Nanoveu for the purposes of providing an overview of the company and its products.

This presentation does not constitute investment advice. Neither does this presentation nor the information contained in it constitute an offer, invitation, solicitation or recommendation in relation to the purchase or sale of shares in any jurisdiction. This presentation does not take into account any person's particular investment objectives, financial resources or other relevant circumstances and the opinions and recommendations in this presentation are not intended to represent recommendations of particular investments to particular persons. Nanoveu does not make any representation or warranty, express or implied, as to the accuracy or completeness of any information, statements, opinions, estimates, forecasts or other representations contained in this presentation. No responsibility for any errors or omissions from this presentation arising out of negligence or otherwise is accepted.

This presentation may include forward-looking statements. Forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions, which are outside the control of Nanoveu. Given these uncertainties, readers are cautioned not to place reliance on forward looking statements.

Any forward looking statements in this presentation speak only at the date of issue of this presentation subject to any continuing obligations under applicable law, Nanoveu does not undertake any obligation to update or revise any information or any of the forward looking statements in this presentation only changes in events, conditions or circumstances on which any such forward looking statement is based.

This document is provided for information purposes only. It is not an offer of sale nor a solicitation of any kind. It is recommended that anybody reviewing the statements here with a view for investment obtain independent professional advice.

2

only

COMPANY OVERVIEW

• Nanoveu (ASX:NVU) is an innovative tech solution company.
• Developed a suite of technologies and products to protect against viruses and bacteria, including COVID-19/SARS 2CoV.1
• With these developments, Nanoveu are leading a new world of antiviral self disinfectants.

ersonal use

Shareholder Breakdown

56.8%		Top 20 Shareholders*
28.7%		Board and Management

Capital Structure

ASX Code	NVU
Shares on Issue	209.2m
Options on Issue	29.1m
Share Price (as 23 March 2022)	A$0.031
Share Price - 52 Week Trading Range	$0.026 - $0.085
Market Capitalisation	A$6.5m
Cash (31 December 2021)	~A$2.0 million
Number of shareholders (2 February 2022)	883

1 See ASX Announcements of 15 April 2020, 5 May 2020, 25 May 2020, 18 February 2021 and 28 July 2021 for the testing performed and the results.

3

ersonal use only

INVESTMENT HIGHLIGHTS

Successful commercialisation of Nanoshield™ Antimicrobial and Antiviral products

Strong international distribution network for Nanoshield™

Nanoshield™ meets leading global regulatory health and environmental standard Tier-1 global customers including Nestlé Group's Professional Services

Strong product development pipeline with low capital investment for new products Reviewing potential acquisitions that are accretive to scale

Antiviral and antibacterial products are a high growth market1

1 - https://www.grandviewresearch.com/industry-analysis/antimicrobial-coatings-market

4